Gene: EXOC5

10640
HSEC10|PRO1912|SEC10|SEC10L1|SEC10P
exocyst complex component 5
protein-coding
14q22.3
Ensembl:ENSG00000070367 MIM:604469 Vega:OTTHUMG00000171309 UniprotKB:O00471
NC_000014.9
SNP Mapped
AD
0   
NA (AD)  NA (ND)   (Frontal_Cortex)
7.031e-2 (AD)  2.724e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs17093036chr14:57267302 (GRCh38.p7)C>Galcohol dependenceSNV(Single Nucleotide Variation)
rs6573140chr14:57266276 (GRCh38.p7)T>Galcohol dependenceSNV(Single Nucleotide Variation)
rs10147752chr14:57265552 (GRCh38.p7)A>Galcohol dependenceSNV(Single Nucleotide Variation)
rs11850616chr14:57265255 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs10141911chr14:57264133 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs10141811chr14:57264030 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs716690chr14:57261934 (GRCh38.p7)C>A / C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs10133300chr14:57256175 (GRCh38.p7)G>Talcohol dependenceSNV(Single Nucleotide Variation)
rs7147218chr14:57255339 (GRCh38.p7)T>C / T>Galcohol dependenceSNV(Single Nucleotide Variation)
rs10130359chr14:57249675 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs9323304chr14:57245764 (GRCh38.p7)A>C / A>Talcohol dependenceSNV(Single Nucleotide Variation)
rs6573137chr14:57233186 (GRCh38.p7)A>G / A>Talcohol dependenceSNV(Single Nucleotide Variation)
rs7155721chr14:57230712 (GRCh38.p7)A>Calcohol dependenceSNV(Single Nucleotide Variation)
rs10147790chr14:57226318 (GRCh38.p7)T>Aalcohol dependenceSNV(Single Nucleotide Variation)
rs11846972chr14:57222138 (GRCh38.p7)A>Talcohol dependenceSNV(Single Nucleotide Variation)
rs1555788chr14:57218454 (GRCh38.p7)A>Calcohol dependenceSNV(Single Nucleotide Variation)
rs60328452chr14:57217583 (GRCh38.p7)A>Talcohol dependenceSNV(Single Nucleotide Variation)
rs10135879chr14:57217416 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs4569162chr14:57215062 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs10140993chr14:57212739 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs10150771chr14:57208467 (GRCh38.p7)C>G / C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs10137379chr14:57208149 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs7141911chr14:57206153 (GRCh38.p7)A>G / A>Talcohol dependenceSNV(Single Nucleotide Variation)
rs3742578chr14:57205997 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs3742577chr14:57205822 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs8003535chr14:57205286 (GRCh38.p7)G>A / G>Talcohol dependenceSNV(Single Nucleotide Variation)
rs7157608chr14:57204497 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs4612984chr14:57204241 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs10134311chr14:57203324 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs11851015chr14:57202815 (GRCh38.p7)A>Galcohol dependenceSNV(Single Nucleotide Variation)
rs10137456chr14:57202285 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs10135064chr14:57202141 (GRCh38.p7)T>C / T>Galcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
MIB10.919
SMAD20.916
SERBP10.9
RAD210.892
TM9SF30.89
SMARCA50.887
UBL30.884
USP80.88
USP10.88
SYNCRIP0.878

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.667
OR4F29-0.66
PTGDR2-0.205
NUTM2E-0.187
RNF223-0.185
NPIPA2-0.181
RSPO1-0.173
MUC6-0.172
MMP23B-0.169
OR4F16-0.166

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0326681-nitropyrene1-nitropyrene results in increased expression of EXOC5 mRNA19041380
C5112952,2',4,4'-tetrabromodiphenyl ether"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of EXOC5 mRNA"25614096
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXOC5 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXOC5 mRNA"27188386
C0326424-aminophenylarsenoxide4-aminophenylarsenoxide binds to EXOC5 protein26598702
C0326424-aminophenylarsenoxidearsenic trioxide inhibits the reaction [4-aminophenylarsenoxide binds to EXOC5 protein]26598702
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXOC5 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXOC5 mRNA"27188386
D000082AcetaminophenAcetaminophen results in decreased expression of EXOC5 mRNA21420995
D000643Ammonium ChlorideAmmonium Chloride affects the expression of EXOC5 mRNA16483693
D018501Antirheumatic AgentsAntirheumatic Agents results in increased expression of EXOC5 mRNA24449571
C006632arsenic trioxidearsenic trioxide inhibits the reaction [4-aminophenylarsenoxide binds to EXOC5 protein]26598702
D001280AtrazineAtrazine results in decreased expression of EXOC5 mRNA22378314
D0151237,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of EXOC5 mRNA"19150397|2001819
C006780bisphenol Abisphenol A affects the expression of EXOC5 mRNA21786754
C006780bisphenol Abisphenol A results in decreased expression of EXOC5 mRNA25181051
C006780bisphenol Abisphenol A results in increased methylation of EXOC5 gene28505145
C006780bisphenol Abisphenol A results in increased expression of EXOC5 mRNA26794494
C037123cadmium sulfate[cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of EXOC5 mRNA18654764
C018021cobaltous chloride[cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of EXOC5 mRNA18654764
D003993Dibutyl PhthalateDibutyl Phthalate results in increased expression of EXOC5 mRNA17361019|2126653
D002945CisplatinCisplatin results in decreased expression of EXOC5 mRNA27392435
C000944dicrotophosdicrotophos results in decreased expression of EXOC5 mRNA28302478
D004726EndosulfanEndosulfan results in increased expression of EXOC5 mRNA26615145
D005419FlavonoidsFlavonoids results in decreased expression of EXOC5 mRNA18035473
C544151jinfukangjinfukang results in decreased expression of EXOC5 mRNA27392435
C029891lead chloride[cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of EXOC5 mRNA18654764
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of EXOC5 mRNA28001369
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in increased expression of EXOC5 mRNA23649840
D010126OzoneOzone results in increased expression of EXOC5 mRNA28652203
D010795Phthalic AcidsPhthalic Acids results in increased expression of EXOC5 mRNA21061450
D010936Plant ExtractsPlant Extracts results in increased expression of EXOC5 mRNA23557933
D011078Polychlorinated BiphenylsPolychlorinated Biphenyls affects the expression of EXOC5 mRNA21334430
D011794QuercetinQuercetin results in decreased expression of EXOC5 mRNA21632981
C009277sodium arsenatesodium arsenate results in decreased expression of EXOC5 mRNA21795629
C009277sodium arsenatesodium arsenate results in increased expression of EXOC5 mRNA21795629
D013853ThioacetamideThioacetamide results in increased expression of EXOC5 mRNA23411599
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXOC5 mRNA"27188386
C012589trichostatin Atrichostatin A results in decreased expression of EXOC5 mRNA24935251|2627250
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXOC5 mRNA"27188386
D014635Valproic AcidValproic Acid results in decreased expression of EXOC5 mRNA23179753|2627250
D014635Valproic AcidValproic Acid results in decreased methylation of EXOC5 gene29154799
D001335Vehicle EmissionsVehicle Emissions affects the methylation of EXOC5 gene25560391
C088658zoledronic acidzoledronic acid results in increased expression of EXOC5 mRNA20977926

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005515protein binding-IPI21516116  25416956  25910212  26871637  27173435  
GO:0017160Ral GTPase binding-IPI24056301  
GO:0047485protein N-terminus binding-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0006887exocytosis-IBA21873635  
GO:0006892post-Golgi vesicle-mediated transport-TAS9119050  
GO:0006893Golgi to plasma membrane transport-IBA21873635  
GO:0015031protein transport-IEA-  
GO:0048278vesicle docking-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0000145exocyst-IBA21873635  
GO:0005737cytoplasm-TAS9119050  
GO:0005829cytosol-TAS-  
GO:0030496midbody-IEA-  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence
R-HSA-1445148Translocation of GLUT4 to the plasma membraneIEA
R-HSA-1852241Organelle biogenesis and maintenanceTAS
R-HSA-199991Membrane TraffickingIEA
R-HSA-264876Insulin processingTAS
R-HSA-2980736Peptide hormone metabolismTAS
R-HSA-392499Metabolism of proteinsTAS
R-HSA-5617833Cilium AssemblyTAS
R-HSA-5620916VxPx cargo-targeting to ciliumTAS
R-HSA-5620920Cargo trafficking to the periciliary membraneTAS
R-HSA-5653656Vesicle-mediated transportIEA

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal